The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials

. 2023 Mar 01 ; 21 (3) : 494-506. [epub] 20230301

Jazyk angličtina Země Spojené státy americké Médium electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid36727247
Odkazy

PubMed 36727247
DOI 10.11124/jbies-22-00430
PII: 02174543-202303000-00005
Knihovny.cz E-zdroje

JBI recently began the process of updating and revising its suite of critical appraisal tools to ensure that these tools remain compatible with recent developments within risk of bias science. Following a rigorous development process led by the JBI Effectiveness Methodology Group, this paper presents the revised critical appraisal tool for the assessment of risk of bias for randomized controlled trials. This paper also presents practical guidance on how the questions of this tool are to be interpreted and applied by systematic reviewers, while providing topical examples. We also discuss the major changes made to this tool compared to the previous version and justification for why these changes facilitate best-practice methodologies in this field.

Zobrazit více v PubMed

Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth 2020;18(10):2127–33.

Aromataris E, Munn Z. Aromataris E, Munn Z Chapter 1: JBI Systematic Reviews. JBI Manual for Evidence Synthesis [internet]. Adelaide, JBI; 2020 [cited 2022 Nov 29]. Available from: https://synthesismanual.jbi.global .

Porritt K, Gomersall J, Lockwood C. JBI's systematic reviews: study selection and critical appraisal. Am J Nurs 2014;114(6):47–52.

Tufanaru C, Munn Z, Aromataris E, Campbell J, Hopp L Aromataris E, Munn Z. Chapter 3: Systematic reviews of effectiveness. JBI Manual for Evidence Synthesis [internet]. Adelaide, JBI; 2020 [cited 2022 Nov 29]. Available from: https://synthesismanual.jbi.global .

Sterne JA, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:1–8.

Stone JC, Glass K, Clark J, Munn Z, Tugwell P, Doi SAR. A unified framework for bias assessment in clinical research. Int J Evid Based Healthc 2019;17(2):106–20.

Stone JC, Gurunathan U, Aromataris E, Glass K, Tugwell P, Munn Z, et al. Bias assessment in outcomes research: the role of relative versus absolute approaches. Value Health 2021;24(8):1145–9.

Barker TH, Stone JC, Sears K, Klugar M, Leonardi-Bee J, Tufanaru C, et al. Revising the JBI quantitative critical appraisal tools to improve their applicability: an overview of methods and the development process. JBI Evid Synth 2023;21(3):478–93.

Jordan Z, Lockwood C, Aromataris E, Pilla B, Porritt K, Klugar M, et al. JBI series paper 1: Introducing JBI and the JBI Model of EHBC. J Clin Epidemiol 2022;150:191–5.

Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 2021;372:n160.

GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490.

Schünemann HJ, Higgins JP, Vist GE, Glasziou P, Akl EA, Skoetz N, Guyatt GH Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Chapter 14 Completing ‘Summary of findings’ tables and grading the certainty of the evidence. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 [2022 Nov 29]. Available from: https://training.cochrane.org/handbook .

Aromataris E, Stern C, Lockwood C, Barker TH, Klugar M, Jadotte Y, et al. JBI series paper 2: tailored evidence synthesis approaches are required to answer diverse questions: a pragmatic evidence synthesis toolkit from JBI. J Clin Epidemiol 2022;150:196–202.

Stone J, Gurunathan U, Glass K, Munn Z, Tugwell P, Doi SAR. Stratification by quality induced selection bias in a meta-analysis of clinical trials. J Clin Epidemiol 2019;107:51–9.

Greenland S, O'Rourke K. On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions. Biostatistics 2001;2(4):463–71.

Stone JC, Glass K, Munn Z, Tugwell P, Doi SAR. Comparison of bias adjustment methods in meta-analysis suggests that quality effects modeling may have less limitations than other approaches. J Clin Epidemiol 2020;117:36–45.

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...